STOCK TITAN

BlueLinx (NYSE: BXC) investors approve pay, plan and retain director Lewis

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

BlueLinx Holdings Inc. reported results from its 2026 Annual Meeting of Stockholders, where nine directors were up for election, three key governance items were on the ballot, and an equity incentive plan amendment was considered.

Stockholders re-elected eight directors, while former CEO Mitchell B. Lewis did not receive a majority of votes cast for his seat. In line with the company’s bylaws, he tendered an irrevocable resignation offer, which the board, following a unanimous recommendation from the Nominating and Governance Committee, unanimously rejected after reviewing his experience, independence status under NYSE standards and overall board composition.

Stockholders also ratified Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending January 2, 2027, approved the advisory vote on executive compensation, and approved an amendment to the 2021 Long-Term Incentive Plan to increase the shares reserved for issuance. Lewis will step down as chairman and member of the Nominating Committee, with Marietta Edmunds Zakas becoming its new chair.

Positive

  • None.

Negative

  • None.

Insights

Shareholders approved all proposals while the board retained a contested director but shifted his governance role.

BlueLinx investors supported auditor ratification, executive pay and expansion of the 2021 Long-Term Incentive Plan, signaling alignment with the board on core governance and compensation structures. The meeting had strong participation, with 7,133,560 shares represented out of 7,867,196 outstanding.

Mitchell B. Lewis failed to secure a majority of votes cast, largely after proxy advisors recommended voting against his re-election due to his Nominating Committee role and non-independence under their guidelines. The board, however, deemed him independent under NYSE standards since December 2024 and chose to retain him while removing him from that committee.

Overall, these outcomes maintain continuity in board composition and compensation policy, while modestly adjusting governance responsibilities. The impact on the broader investment case appears limited, and future proxy materials may provide additional context on how the revised committee structure operates over subsequent annual cycles.

Item 5.07 Submission of Matters to a Vote of Security Holders Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Item 8.01 Other Events Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Shares outstanding 7,867,196 shares Common stock issued and outstanding as of March 20, 2026
Shares represented at meeting 7,133,560 shares Common stock represented in person or by proxy at 2026 Annual Meeting
Auditor ratification votes for 7,122,739 votes For ratifying Ernst & Young LLP as auditor
Say-on-pay votes for 5,874,819 votes For advisory approval of executive compensation
Incentive plan amendment votes for 3,843,084 votes For increasing shares reserved under 2021 Long-Term Incentive Plan
Lewis re-election votes for 2,604,527 votes Votes supporting Mitchell B. Lewis’s director re-election
Lewis re-election votes against 3,325,567 votes Votes opposing Mitchell B. Lewis’s director re-election
broker non-votes financial
"For | | Against | | Abstain | | Broker Non-Votes 3,843,084 | | 2,090,468 | | 1,599 | | 1,198,409"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
majority voting and director resignation policy regulatory
"in accordance with the majority voting and director resignation policy included in Company’s bylaws"
Nominating and Governance Committee financial
"Mr. Lewis was appointed to the Nominating and Governance Committee of the Board"
A nominating and governance committee is a group of board members tasked with choosing and evaluating directors, planning leadership succession, and setting the company’s board-related rules and ethical standards. Think of it as the company’s hiring and rule-making panel for its top overseers. Its work matters to investors because it shapes who governs the company, how leadership transitions are handled, and whether the board can effectively oversee management and protect shareholder interests.
independent registered public accounting firm financial
"ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm"
An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.
emerging growth company regulatory
"Emerging growth company o On May 14, 2026, BlueLinx Holdings Inc."
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
independent director financial
"since December 2024, Mr. Lewis has qualified as an independent director under applicable NYSE independence standards"
An independent director is a member of a company's board of directors who is not involved in the company's day-to-day operations and has no significant relationships with the company that could influence their judgment. Their role is to provide unbiased oversight and ensure the company is managed in the best interests of all shareholders. This helps build trust and confidence among investors by promoting transparency and accountability.
false 0001301787 0001301787 2026-05-14 2026-05-14 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

FORM 8-K

 

  

CURRENT REPORT

Pursuant to Section 13 or 15(d) of  The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): May 19, 2026  (May 14, 2026)

 

 

BlueLinx Holdings Inc.

(Exact name of registrant as specified in its charter)

 

 

Delaware   001-32383   77-0627356

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

 

1950 Spectrum Circle, Suite 300, Marietta, Georgia   30067
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code (770) 953-7000

 

 

 

(Former name or former address, if changed since last report.)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol(s) Name of each exchange on which
registered
Common Stock, par value $0.01 per share BXC New York Stock Exchange

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

 

 

 

 

 

Item 5.07 Submission of Matters to a Vote of Security Holders

 

On May 14, 2026, BlueLinx Holdings Inc. (the “Company”) held its Annual Meeting of Stockholders (the “2026 Annual Meeting”) to (1) elect nine directors to hold office until the Company’s 2027 Annual Meeting of Stockholders, or until their successors are duly elected and qualified; (2) ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the Company’s current fiscal year ending January 2, 2027; (3) approve an advisory, non-binding resolution regarding the executive compensation described in the Company’s Proxy Statement for the 2026 Annual Meeting; and (4) approve an amendment to the Company’s 2021 Long-Term Incentive Plan (the “2021 Plan”) to increase the number of shares of common stock reserved for issuance under the 2021 Plan.

 

At the close of business of March 20, 2026, the record date of the 2026 Annual Meeting, an aggregate of 7,867,196 shares of the Company’s common stock were issued and outstanding. At the meeting, 7,133,560 shares of the Company’s common stock were represented in person or by proxy; therefore, a quorum was present.

 

At the 2026 Annual Meeting, the Company’s stockholders voted as follows:

 

(1) For the election of the below-named nominees to the Board of Directors (the “Board”) of the Company:

 

Nominees  For  Against  Abstain  Broker
Non-Votes
Christina M. Corley  5,761,068  173,346  737  1,198,409
Anuj Dhanda  5,080,318  849,611  5,222  1,198,409
Kim S. Fennebresque  5,503,150  430,576  1,425  1,198,409
Keith A. Haas  5,643,086  288,263  3,802  1,198,409
Mitchell B. Lewis  2,604,527  3,325,567  5,057  1,198,409
Shyam K. Reddy  5,774,261  156,801  4,089  1,198,409
J. David Smith  5,761,556  172,864  731  1,198,409
Carol B. Yancey  5,768,008  166,699  444  1,198,409
Marietta Edmunds Zakas  5,620,269  313,317  1,565  1,198,409

 

Accordingly, the stockholders re-elected each of the above nominees, other than Mr. Lewis, as a director of the Company. For additional information regarding Mr. Lewis, see Item 8.01 below.

 

(2) For the ratification of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the Company’s current fiscal year ending January 2, 2027:

 

For  Against  Abstain
7,122,739  10,258  563

 

(3) For the approval of the advisory, non-binding resolution regarding the executive compensation described in the Company’s Proxy Statement for the 2026 Annual Meeting:

 

For  Against  Abstain  Broker Non-Votes
5,874,819  55,435  4,897  1,198,409

 

(4) For the approval of an amendment to the Company’s 2021 Plan to increase the number of shares of common stock reserved for issuance under the 2021 Plan.

 

For  Against  Abstain  Broker Non-Votes
3,843,084  2,090,468  1,599  1,198,409

 

Accordingly, the Company’s stockholders approved proposals 2, 3 and 4 at the 2026 Annual Meeting.

 

 

 

 

Item 8.01 Other Events

 

At the 2026 Annual Meeting, Mr. Lewis did not receive a majority of votes cast with respect to his re-election to the Board. As a result, and in accordance with the majority voting and director resignation policy included in Company’s bylaws (as described in the Company’s definitive proxy statement for the 2026 Annual Meeting, filed with the Securities and Exchange Commission (the “SEC”) on April 9, 2026), Mr. Lewis tendered his irrevocable offer of resignation to the Board on May 14, 2026.

 

Institutional Shareholder Services (“ISS”) and Glass Lewis & Co. (“Glass Lewis”) had previously recommended each year from Mr. Lewis’ retirement in 2021 through 2025 that stockholders of the Company vote “for” Mr. Lewis as director of of the Company. Prior to the 2026 Annual Meeting, ISS and Glass Lewis recommended a vote “against” Mr. Lewis’ re-election as a director of the Company at the 2026 Annual Meeting because (1) Mr. Lewis was appointed to the Nominating and Governance Committee of the Board (the “Nominating Committee”) and (2) Mr. Lewis previously served as the Company’s President and Chief Executive Officer until 2021, and is therefore considered non-independent under applicable ISS and Glass Lewis voting guidelines. Mr. Lewis’ appointment in 2025 to the Nominating Committee and as the Nominating Committee Chairman took place following the Board’s determination that Mr. Lewis qualified as independent under applicable New York Stock Exchange (“NYSE”) and SEC independence standards, after more than three years had elapsed following his retirement as the Company’s Chief Executive Officer.

 

The Board, upon the unanimous recommendation of the Nominating Committee and pursuant to the Company’s bylaws, considered Mr. Lewis’ irrevocable offer of resignation and unanimously rejected his offer to resign, determining that Mr. Lewis shall remain as a director on the Board. In accordance with the Company’s bylaws, Mr. Lewis recused himself from both Nominating Committee and Board deliberations regarding this determination. In considering whether to accept or reject Mr. Lewis’ resignation, the Board, in consultation with the Nominating Committee, considered all factors believed relevant, including without limitation: (i) the underlying reasons for Mr. Lewis not receiving a majority of votes cast in favor of his re-election as director (which are attributable to Mr. Lewis’ service as a member of the Nominating Committee, which, in turn, resulted in the ISS and Glass Lewis “against” recommendations); (ii) Mr. Lewis’ resignation as Chairman and as a member of the Nominating Committee; (iii) the tenure and qualifications of Mr. Lewis; (iv) Mr. Lewis’ experience as the Company’s former Chief Executive Officer, as well as his financial expertise, mergers and acquisitions expertise, operational expertise, management advisory expertise, building materials, manufacturing and distribution experience, and former third party building products public company board service; (v) Mr. Lewis’ past and expected future contributions to the Board; (vi) the overall composition of the Board; (vii) since December 2024, Mr. Lewis has qualified as an independent director under applicable NYSE independence standards; and (viii) whether accepting the tendered resignation would cause the Company to fail to meet any applicable rule or regulation, including under NYSE listing standards and federal securities laws.

 

Mr. Lewis will be replaced as Chairman of the Nominating Committee by Marietta Edmunds Zakas.

 

Item 9.01 Financial Statements and Exhibits.

 

(d)Exhibits:

 

The following exhibits are attached with this Current Report on Form 8-K:

 

Exhibit No.   Exhibit Description
104   Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    BlueLinx Holdings Inc.
     
Dated: May 19, 2026 By: /s/ Shyam K. Reddy
    Shyam K. Reddy
    President and Chief Executive Officer

 

 

 

FAQ

What did BlueLinx (BXC) shareholders vote on at the 2026 Annual Meeting?

Shareholders voted on electing nine directors, ratifying Ernst & Young LLP as auditor, approving an advisory say-on-pay resolution, and amending the 2021 Long-Term Incentive Plan to increase shares reserved for issuance. All proposals other than Mitchell B. Lewis’s director re-election received strong shareholder support.

Did BlueLinx (BXC) shareholders approve the amendment to the 2021 Long-Term Incentive Plan?

Yes, shareholders approved the amendment to the 2021 Long-Term Incentive Plan. The proposal received 3,843,084 votes for, 2,090,468 against and 1,599 abstentions, with 1,198,409 broker non-votes. This increases the number of common shares reserved for future equity-based awards under the plan.

How did BlueLinx (BXC) shareholders vote on executive compensation in 2026?

Shareholders approved the advisory, non-binding resolution on executive compensation. The say-on-pay proposal received 5,874,819 votes for, 55,435 against and 4,897 abstentions, plus 1,198,409 broker non-votes, indicating broad shareholder support for the company’s disclosed executive pay program at the 2026 meeting.

What happened with BlueLinx (BXC) director Mitchell B. Lewis’s 2026 re-election?

Mitchell B. Lewis did not receive a majority of votes cast for his re-election, with 2,604,527 votes for and 3,325,567 against. Pursuant to company bylaws, he tendered an irrevocable resignation offer, but the board unanimously rejected it after review, allowing him to remain a director.

Why did the BlueLinx (BXC) board keep Mitchell B. Lewis on the board after the vote?

The board cited Lewis’s experience, tenure, independence under NYSE standards since December 2024, and his contributions. It concluded low support was driven by proxy advisor recommendations tied to his Nominating Committee role. After deliberation, the board rejected his resignation but removed him as Nominating Committee chair and member.

Who will chair the BlueLinx (BXC) Nominating and Governance Committee after the 2026 meeting?

Following the 2026 Annual Meeting, Marietta Edmunds Zakas will serve as chair of the Nominating and Governance Committee. Mitchell B. Lewis resigned as chairman and member of the committee as part of the board’s response to the shareholder vote and related governance considerations.

Did BlueLinx (BXC) shareholders ratify Ernst & Young as auditor for 2026?

Yes, shareholders ratified Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending January 2, 2027. The ratification proposal received 7,122,739 votes for, 10,258 against and 563 abstentions, reflecting very strong support for the company’s external auditor choice.

Filing Exhibits & Attachments

3 documents